PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3616 (109th)

Inflammatory Bowel Disease Research Act

openUnited States· United States Congress· EN

Introduced

29 July 2005

Last action

10 November 2005 · Introduced

Status

Sponsor introductory remarks on measure. (CR E2334)

Sponsors

Rep. Kelly, Sue W. [R-NY-19], Rep. Cardin, Benjamin L. [D-MD-3], Rep. Jackson, Jesse L., Jr. [D-IL-2], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Weiner, Anthony D. [D-NY-9], Rep. McNulty, Michael R. [D-NY-23], Rep. Moran, James P. [D-VA-8], Rep. Hinchey, Maurice D. [D-NY-22], Marcy Kaptur, Rep. Taylor, Gene [D-MS-5], Sheila Jackson Lee, Rep. Berry, Marion [D-AR-1], Rep. Cunningham, Randy (Duke) [R-CA-50], Rep. Wexler, Robert [D-FL-19], Rep. Frank, Barney [D-MA-4], Rep. Leach, James A. [R-IA-1], K. Conaway, Rep. Stark, Fortney Pete [D-CA-9], Rep. Platts, Todd Russell [R-PA-19], Rep. Waxman, Henry A. [D-CA-24], SUSAN DAVIS, ROBERT GOODLATTE, Sen. Van Hollen, Chris [D-MD], Rep. Wolf, Frank R. [R-VA-10], Rep. Abercrombie, Neil [D-HI-1], Rep. McCotter, Thaddeus G. [R-MI-11], Rep. McHugh, John M. [R-NY-23], STEVE CHABOT, Rep. LaTourette, Steven C. [R-OH-14], DAVID PRICE, CAROLYN MALONEY, Rep. Honda, Michael M. [D-CA-17], Rep. Marshall, Jim [D-GA-8], Rep. Simmons, Rob [R-CT-2], Rep. Ford, Harold E., Jr. [D-TN-9], Rep. Dicks, Norman D. [D-WA-6], PETER KING, Rep. Gilchrest, Wayne T. [R-MD-1], Rep. Pallone, Frank [D-NJ-6], Rep. Etheridge, Bob [D-NC-2], Rep. Bono Mack, Mary [R-CA-45], ELIOT ENGEL, Rep. Rangel, Charles B. [D-NY-19], Rep. Jones, Stephanie Tubbs [D-OH-11], WM. CLAY, Rep. Lynch, Stephen F. [D-MA-8], Rep. Israel, Steve [D-NY-3], Rep. Wynn, Albert Russell [D-MD-4]

Subjects

Healthcare

Source updated

15 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Inflammatory Bowel Disease Research Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand, intensify, and coordinate the Institute's research activities on inflammatory bowel disease, with an emphasis on: (1) genetic research on susceptibility for inflammatory bowel disease; (2) research targeted to increase knowledge about the causes and complications of inflammatory bowel disease in children; (3) animal model research; (4) clinical research; (5) expansion of the Institute's Inflammatory Bowel Disease Centers program with a focus on pediatric research; and (6) other research initiatives identified in specified documents. Requires the Director of the Centers for Disease Control and Prevention (CDC) to prepare a National Inflammatory Bowel Disease Action Plan to: (1) address the burden of inflammatory bowel disease in both adult and pediatric populations; (2) address strategies for determining the prevalence of the disease in the United States and the unique demographic characteristics of the patient community; (3) focus on strategies for increasing awareness about the disease within the general public and the health care community; and (4) address mechanisms designed to prevent the progression of the disease and the development of complications.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 29 July 2005

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 29 July 2005

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 29 July 2005

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 5 August 2005

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 10 November 2005

    Introduced

    Sponsor introductory remarks on measure. (CR E2334)

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Showing 48 of 105 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.